Clinical Trial Update: The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of fluoxetine for refractory primary mono-symptomatic nocturnal enuresis in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Mansoura University | Conditions: Nocturnal Enuresis | Phase 3 | Status: UNKNOWN